High materiality8/10
Benitec Biopharma initiated with an Outperform at Wedbush
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush initiates BNTC with Outperform; target $16; current price $11.58.
- Wedbush Outperform; target $16; price $11.58
Key facts
- 01
Target: $16
- 02
Posted price: $11.58
- 03
Analyst firm: Wedbush
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.